Immunogenomics papers: Difference between revisions
From genomewiki
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
** Profile of somatic versus germline mutations | ** Profile of somatic versus germline mutations | ||
* [http://www.pnas.org/content/106/48/20216 Glanville 2009, Pons lab, Pfizer] | * [http://www.pnas.org/content/106/48/20216 Glanville 2009, Pons lab, Pfizer] | ||
** | * [http://www.ncbi.nlm.nih.gov/pubmed/14636599 Zemlin 2003] | ||
** CDR3 composition is very different between human and mouse | |||
== Reviews == | == Reviews == | ||
* [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038007/ Fisher 2010] | * [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038007/ Fisher 2010] | ||
Revision as of 22:04, 14 July 2011
- Boyd et al, Fire lab, Stanford
- sequenced IGH-locus with BIOMED2 primers
- Tomlinson 1996
- Sanger sequencing of IGH
- Profile of somatic versus germline mutations
- Glanville 2009, Pons lab, Pfizer
- Zemlin 2003
- CDR3 composition is very different between human and mouse
